Vehafarm SRL

2.7 FTE

Vehafarm reported total assets of €5.72m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jan 2026), with 2.7 full-time equivalents.

Company number (CBE) 0890.930.746 · VAT BE0890930746
8554 Zwevegem
active in Raising of hens (NACE 01471)
operating since 18 Jul 2007 (≈ 19 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Vehafarm shows with a free account.

See the score
Profile
SRL Micro · 2.7 FTE since 2007
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result492,927 €
Equity€2.11m
Cash610,823 €
EBITDA€1.01m
Total assets€5.72m
Headcount (avg FTE)2.7
Solvency36.9%
The line marks its sector median: 52.7% (207 companies).

Change 2023 → 2025: Equity +53 % Total assets +7 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Vehafarm's annual accounts

20252024202320212020
Net result492,927 €
Equity€2.11m
Cash610,823 €
EBITDA€1.01m
Total assets€5.72m

Filed annual accounts

  • Year ended 31 May 2025filed on 06 Jan 2026
  • Year ended 31 May 2024filed on 29 Jan 2025
  • Year ended 31 May 2023filed on 04 Jan 2024
  • Year ended 31 May 2021filed on 21 Dec 2021
  • Year ended 31 May 2020filed on 04 Jan 2021

Vehafarm's financial analysis

Management and control of Vehafarm

1 active director(s) in the register.

Vehafarm's shareholders and holdings →

Vehafarm's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0890.930.746
VAT number
BE0890930746
Peppol
Registered · 0208:0890930746 · as of 10 Nov 2026
Legal form
SRL
Incorporated
18 Jul 2007
Registered office
8554 Zwevegem
Size
Micro · 2.7 FTE
Latest accounts
2025 · filed on 06 Jan 2026
Activity
Raising of hens (NACE 01471)

Vehafarm (SRL) has been based in Zwevegem since 2007, active in: raising of hens. For 2025, it reports a net profit of 492,927 € and equity of €2.11m; its revenue is not published. With 2.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 36.9%, below the median of its sector (52.7%).

Companies similar to Vehafarm

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Vehafarm

What is the revenue of Vehafarm?

Vehafarm files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Vehafarm?

In Belgium, the VAT number is the company number prefixed with BE: BE0890930746 for Vehafarm, if the company is VAT-registered. Its company number (CBE) is 0890.930.746.

Where is the registered office of Vehafarm?

According to the CBE register, the registered office of Vehafarm is in 8554 Zwevegem.

What is the equity of Vehafarm?

At the close of the 2025 financial year, the equity of Vehafarm amounts to 2,111,276 €, a solvency of 36.9% of total assets.

How many people work at Vehafarm?

2.7 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Vehafarm?

The register lists 1 active mandates at Vehafarm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Vehafarm

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 10 Aug 2026

No credit card, no commitment.

What each plan unlocks →